In PKD, TP reduces cyst burden and improves renal function through multiple pathways: PC2-dependent Ca2+ release, inhibition of the JAK/STAT pathway, and downregulation of proliferation markers (Ki-67, PCNA). Here, SOAT1 is linked to cyst.